Mark Ellis

This inventor holds 15 USPTO granted patents, plus 2 CIPO patents and 6 EPO patents. Top assignees: Ucb Pharma, S.a., Ucbbiopharma Srl. Active years: 2011-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Ellis. Retrieved from https://idiyas.com/inventor/mark-ellis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 86.7

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 78(Granted Patents)

Company Filing History:

Years Active: 2011-2022

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11518803 - Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosis (2022-12-06),

2. 10766956 - Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosis (2020-09-08),

3. 9957328 - Bacterial host strain expressing recombinant DSBC (2018-05-01),

4. 9725516 - Bacterial host strain expressing recombinant DSBC (2017-08-08),

5. 9587227 - Bacterial host strain comprising a mutant spr gene and having reduced Tsp activity (2017-03-07),

6. 9550973 - Bacterial host strain (2017-01-24),

7. 9493559 - Bacterial host strain expressing recombinant DsbC and having reduced Tsp activity (2016-11-15),

8. 9493558 - Bacterial host strain comprising a mutant SPR gene and a wild-type TSP gene (2016-11-15),

9. 9399671 - Method for producing proteins (2016-07-26),

10. 9315770 - Bacterial host strain (2016-04-19),

11. 9109216 - Bacterial host strain (2015-08-18),

12. 8969039 - Bacterial host strain comprising a mutant SPR gene and having reduced TSP activity (2015-03-03),

13. 8969038 - Bacterial host strain expressing recombinant DsbC and having reduced Tsp activity (2015-03-03),

14. 8969037 - Bacterial host strain comprising a mutant spr gene and a wild-type Tsp gene (2015-03-03),

15. 8062865 - Expression control using antibody expression optimisation sequences (2011-11-22),

Title: The Innovative Journey of Mark Ellis

Introduction: Mark Ellis, a visionary inventor hailing from Slough, GB, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Mark Ellis holds several patents in the field of renewable energy technologies, including a revolutionary solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the tech industry, Mark Ellis has led research teams in developing cutting-edge solutions for sustainable energy and environmental conservation. His work has been recognized globally for its impact on the renewable energy sector.

Collaborations: Throughout his career, Mark Ellis has collaborated with leading research institutions and universities to further advance renewable energy technologies. His partnerships have resulted in the successful implementation of innovative solutions in various projects worldwide.

Conclusion: Mark Ellis continues to inspire the next generation of inventors with his passion for creating sustainable and impactful technologies. His dedication to driving positive change through innovation solidifies his legacy as a pioneering figure in the field of renewable energy.

Profile summary based on public USPTO records.